Share Price and Basic Stock Data
Last Updated: October 28, 2025, 4:04 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Chennai Meenakshi Multispeciality Hospital Ltd operates within the Hospitals & Medical Services industry, showcasing a market capitalization of ₹39.6 Cr and a share price of ₹53.00. The company reported a total revenue from operations of ₹38.19 Cr for the fiscal year ending March 2023, which reflects an increase from ₹30.86 Cr in the previous fiscal year. This upward trend in revenue continued with reported figures of ₹37.38 Cr for FY 2024 and ₹33.76 Cr for FY 2025. Notably, the quarterly sales data indicates a recovery trajectory with ₹10.07 Cr recorded in December 2023, following a dip in previous quarters. The company’s sales performance demonstrates resilience amidst industry challenges, although the overall growth rate remains modest compared to sector averages. The healthcare sector in India has been experiencing significant growth, driven by increasing demand for healthcare services, yet Chennai Meenakshi’s growth appears to lag behind broader sector growth rates. This discrepancy may suggest the need for strategic operational improvements to enhance market competitiveness.
Profitability and Efficiency Metrics
Chennai Meenakshi’s profitability metrics present a mixed picture. The company reported an operating profit margin (OPM) of 3.71%, down from a high of 18.60% in FY 2022, indicating a decline in operational efficiency. The net profit for FY 2023 stood at ₹0.89 Cr, but this figure is overshadowed by a reported net loss of ₹1.73 Cr for the trailing twelve months (TTM). The interest coverage ratio (ICR) of 0.71x raises concerns about the company’s ability to meet its interest obligations, particularly given that it has consistently recorded negative net profits in recent quarters. Furthermore, the return on capital employed (ROCE) declined to -5.14% in FY 2025, highlighting inefficiencies in capital utilization. These profitability challenges are compounded by the company’s operating expenses, which have risen significantly, leading to tighter margins. Overall, while there are pockets of operational effectiveness, the declining profitability metrics suggest the need for a strategic overhaul to enhance financial performance.
Balance Sheet Strength and Financial Ratios
Chennai Meenakshi’s balance sheet reveals critical insights into its financial health. The company reported total borrowings of ₹10.63 Cr alongside negative reserves of ₹9.36 Cr, indicating potential liquidity challenges. The total liabilities amounted to ₹22.50 Cr, while total assets were reported at ₹22.50 Cr, reflecting a precarious balance between obligations and resources. The current ratio, standing at 0.53x, is below the ideal threshold of 1, suggesting that the company may struggle to cover short-term liabilities. Additionally, the price-to-book value ratio (P/BV) is notably negative at -12.21x, indicating that the market is valuing the company’s equity at a significant discount to its book value. This could deter potential investors and signal underlying concerns regarding asset valuation. The company’s financial ratios underscore the need for improved capital management strategies and a focus on enhancing shareholder value to restore confidence in its financial stability.
Shareholding Pattern and Investor Confidence
Chennai Meenakshi’s shareholding pattern indicates a significant presence of promoters, who own 57.10% of the company, reflecting a strong commitment to the business. However, the public shareholding has fluctuated, with a reported 42.75% held by the public as of the latest quarter. The presence of domestic institutional investors (DIIs) is minimal, standing at just 0.14%, which may point to a lack of confidence from institutional players regarding the company’s growth prospects. The number of shareholders has seen a slight increase, reaching 8,625, but the overall distribution suggests a reliance on promoter support rather than broader market confidence. This concentrated ownership structure could pose risks if the company does not demonstrate consistent performance improvements. Investor sentiment may also be affected by the company’s recent financial performance, as evidenced by its negative net profits and declining profitability metrics, which could deter potential new investors.
Outlook, Risks, and Final Insight
The outlook for Chennai Meenakshi Multispeciality Hospital Ltd hinges on its ability to address operational inefficiencies and enhance profitability. The substantial reliance on promoter ownership may provide stability, but it also raises concerns about governance and the need for a more diversified investor base. Key risks include ongoing financial losses, a low interest coverage ratio, and negative reserves, which could jeopardize the company’s ability to sustain operations without significant restructuring. Conversely, strengths such as a committed promoter base and a recovering sales trajectory present opportunities for improvement. If the company can implement effective cost control measures and strategic initiatives to boost revenue, it may restore investor confidence and improve its market standing. However, failure to address these challenges could result in prolonged financial instability, limiting growth potential in a competitive healthcare landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Chennai Meenakshi Multispeciality Hospital Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 49.7 Cr. | 148 | 195/140 | 6.69 | 115 | 2.36 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 23.6 Cr. | 22.5 | 37.6/0.00 | 25.5 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 13.1 Cr. | 12.6 | 23.4/12.0 | 145 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 126 Cr. | 67.4 | 98.7/51.4 | 27.4 | 16.1 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 23.2 Cr. | 4.30 | 7.73/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 29,345.43 Cr | 863.52 | 71.93 | 94.85 | 0.30% | 15.48% | 14.81% | 9.04 |
All Competitor Stocks of Chennai Meenakshi Multispeciality Hospital Ltd
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.93 | 6.37 | 7.10 | 7.63 | 9.88 | 9.07 | 9.51 | 10.07 | 9.55 | 8.75 | 8.07 | 8.83 | 9.17 |
| Expenses | 6.88 | 5.87 | 6.44 | 6.84 | 8.84 | 8.66 | 8.96 | 9.80 | 9.07 | 8.68 | 8.29 | 9.20 | 8.83 |
| Operating Profit | 0.05 | 0.50 | 0.66 | 0.79 | 1.04 | 0.41 | 0.55 | 0.27 | 0.48 | 0.07 | -0.22 | -0.37 | 0.34 |
| OPM % | 0.72% | 7.85% | 9.30% | 10.35% | 10.53% | 4.52% | 5.78% | 2.68% | 5.03% | 0.80% | -2.73% | -4.19% | 3.71% |
| Other Income | 0.06 | 0.06 | 0.08 | 0.10 | 0.11 | 0.10 | 0.04 | 0.15 | 0.18 | 0.08 | 0.08 | 0.26 | 0.42 |
| Interest | 0.23 | 0.22 | 0.22 | 0.22 | 0.22 | 0.23 | 0.23 | 0.23 | 0.24 | 0.24 | 0.23 | 0.23 | 0.22 |
| Depreciation | 0.31 | 0.31 | 0.29 | 0.29 | 0.29 | 0.27 | 0.30 | 0.30 | 0.29 | 0.31 | 0.31 | 0.31 | 0.23 |
| Profit before tax | -0.43 | 0.03 | 0.23 | 0.38 | 0.64 | 0.01 | 0.06 | -0.11 | 0.13 | -0.40 | -0.68 | -0.65 | 0.31 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 60.94% | 0.00% | 33.33% | -63.64% | 446.15% | -5.00% | -1.47% | -3.08% | 3.23% |
| Net Profit | -0.43 | 0.04 | 0.23 | 0.38 | 0.25 | 0.02 | 0.04 | -0.04 | -0.44 | -0.38 | -0.67 | -0.63 | 0.31 |
| EPS in Rs | -0.58 | 0.05 | 0.31 | 0.51 | 0.33 | 0.03 | 0.05 | -0.05 | -0.59 | -0.51 | -0.90 | -0.84 | 0.42 |
Last Updated: July 16, 2025, 10:25 am
Below is a detailed analysis of the quarterly data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 9.17 Cr.. The value appears strong and on an upward trend. It has increased from 8.83 Cr. (Dec 2024) to 9.17 Cr., marking an increase of 0.34 Cr..
- For Expenses, as of Mar 2025, the value is 8.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.20 Cr. (Dec 2024) to 8.83 Cr., marking a decrease of 0.37 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.34 Cr.. The value appears strong and on an upward trend. It has increased from -0.37 Cr. (Dec 2024) to 0.34 Cr., marking an increase of 0.71 Cr..
- For OPM %, as of Mar 2025, the value is 3.71%. The value appears strong and on an upward trend. It has increased from -4.19% (Dec 2024) to 3.71%, marking an increase of 7.90%.
- For Other Income, as of Mar 2025, the value is 0.42 Cr.. The value appears strong and on an upward trend. It has increased from 0.26 Cr. (Dec 2024) to 0.42 Cr., marking an increase of 0.16 Cr..
- For Interest, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Dec 2024) to 0.22 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Mar 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Dec 2024) to 0.23 Cr., marking a decrease of 0.08 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -0.65 Cr. (Dec 2024) to 0.31 Cr., marking an increase of 0.96 Cr..
- For Tax %, as of Mar 2025, the value is 3.23%. The value appears to be increasing, which may not be favorable. It has increased from -3.08% (Dec 2024) to 3.23%, marking an increase of 6.31%.
- For Net Profit, as of Mar 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -0.63 Cr. (Dec 2024) to 0.31 Cr., marking an increase of 0.94 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.42. The value appears strong and on an upward trend. It has increased from -0.84 (Dec 2024) to 0.42, marking an increase of 1.26.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:39 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.59 | 18.71 | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 38.19 | 37.38 | 33.76 | 34.72 |
| Expenses | 15.21 | 16.57 | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 35.16 | 35.48 | 33.96 | 35.49 |
| Operating Profit | 2.38 | 2.14 | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 1.90 | -0.20 | -0.77 |
| OPM % | 13.53% | 11.44% | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 7.93% | 5.08% | -0.59% | -2.22% |
| Other Income | 0.30 | -0.54 | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.28 | 0.85 | 1.03 |
| Interest | 1.39 | 1.38 | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.92 | 0.91 | 0.90 |
| Depreciation | 0.81 | 1.19 | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 | 1.16 | 1.14 |
| Profit before tax | 0.48 | -0.97 | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.10 | -1.42 | -1.78 |
| Tax % | 8.33% | 0.00% | 0.00% | 0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | 530.00% | -3.52% | |
| Net Profit | 0.45 | -0.97 | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | -0.43 | -1.37 | -1.73 |
| EPS in Rs | 0.60 | -1.30 | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | -0.58 | -1.83 | -2.31 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -315.56% | 167.01% | -263.08% | 241.51% | -96.67% | 1000.00% | -327.27% | 418.40% | -77.64% | -148.31% | -218.60% |
| Change in YoY Net Profit Growth (%) | 0.00% | 482.57% | -430.09% | 504.59% | -338.18% | 1096.67% | -1327.27% | 745.67% | -496.04% | -70.68% | -70.29% |
Chennai Meenakshi Multispeciality Hospital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 26% |
| 3 Years: | 21% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:56 pm
Balance Sheet
Last Updated: October 10, 2025, 3:45 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Reserves | -11.97 | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.80 | -9.36 |
| Borrowings | 12.74 | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 11.42 | 10.63 |
| Other Liabilities | 10.98 | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.35 | 11.72 | 13.76 |
| Total Liabilities | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 |
| Fixed Assets | 15.11 | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 14.66 | 13.77 |
| CWIP | 0.47 | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.64 | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.16 | 8.15 | 8.73 |
| Total Assets | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 |
Below is a detailed analysis of the balance sheet data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.47 Cr..
- For Reserves, as of Mar 2025, the value is -9.36 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -7.80 Cr. (Mar 2024) to -9.36 Cr., marking a decline of 1.56 Cr..
- For Borrowings, as of Mar 2025, the value is 10.63 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 11.42 Cr. (Mar 2024) to 10.63 Cr., marking a decrease of 0.79 Cr..
- For Other Liabilities, as of Mar 2025, the value is 13.76 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.72 Cr. (Mar 2024) to 13.76 Cr., marking an increase of 2.04 Cr..
- For Total Liabilities, as of Mar 2025, the value is 22.50 Cr.. The value appears to be improving (decreasing). It has decreased from 22.81 Cr. (Mar 2024) to 22.50 Cr., marking a decrease of 0.31 Cr..
- For Fixed Assets, as of Mar 2025, the value is 13.77 Cr.. The value appears to be declining and may need further review. It has decreased from 14.66 Cr. (Mar 2024) to 13.77 Cr., marking a decrease of 0.89 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 8.73 Cr.. The value appears strong and on an upward trend. It has increased from 8.15 Cr. (Mar 2024) to 8.73 Cr., marking an increase of 0.58 Cr..
- For Total Assets, as of Mar 2025, the value is 22.50 Cr.. The value appears to be declining and may need further review. It has decreased from 22.81 Cr. (Mar 2024) to 22.50 Cr., marking a decrease of 0.31 Cr..
However, the Borrowings (10.63 Cr.) are higher than the Reserves (-9.36 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.36 | -9.99 | -9.18 | -10.94 | -8.45 | -10.10 | -9.03 | -10.84 | -4.89 | -7.60 | -9.52 | -10.83 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11.83 | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 11.28 | 6.25 | 8.65 |
| Inventory Days | 36.25 | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 | 21.50 | 24.49 |
| Days Payable | 112.88 | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 88.74 | 51.61 | 89.40 |
| Cash Conversion Cycle | -64.80 | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -54.75 | -23.85 | -56.26 |
| Working Capital Days | -171.61 | -185.72 | -143.60 | -178.91 | -123.83 | -125.76 | -95.83 | -170.78 | -81.73 | -67.28 | -74.02 | -98.71 |
| ROCE % | 22.61% | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% | 11.08% | -5.14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Diluted EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Cash EPS (Rs.) | -0.28 | 0.97 | 2.77 | 6.89 | 0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Revenue From Operations / Share (Rs.) | 46.62 | 51.15 | 38.25 | 42.02 | 26.08 |
| PBDIT / Share (Rs.) | 0.86 | 2.92 | 4.49 | 8.21 | 1.55 |
| PBIT / Share (Rs.) | -0.68 | 1.37 | 2.91 | 6.64 | -0.14 |
| PBT / Share (Rs.) | -1.91 | 0.13 | 1.71 | 5.32 | -1.67 |
| Net Profit / Share (Rs.) | -1.84 | -0.57 | 1.19 | 5.32 | -1.67 |
| PBDIT Margin (%) | 1.86 | 5.70 | 11.73 | 19.54 | 5.93 |
| PBIT Margin (%) | -1.47 | 2.67 | 7.60 | 15.80 | -0.56 |
| PBT Margin (%) | -4.10 | 0.27 | 4.48 | 12.66 | -6.41 |
| Net Profit Margin (%) | -3.94 | -1.11 | 3.11 | 12.66 | -6.41 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 732.31 | -511.80 | 0.00 |
| Return on Capital Employeed (%) | -5.00 | 8.42 | 18.60 | 46.54 | -1.49 |
| Return On Assets (%) | -6.10 | -1.87 | 3.95 | 18.58 | -6.50 |
| Long Term Debt / Equity (X) | -5.63 | -33.52 | 87.39 | -13.68 | -2.41 |
| Total Debt / Equity (X) | -5.63 | -34.86 | 87.39 | -13.68 | -2.41 |
| Asset Turnover Ratio (%) | 1.54 | 1.69 | 1.30 | 1.55 | 1.01 |
| Current Ratio (X) | 0.53 | 0.64 | 0.76 | 0.65 | 0.50 |
| Quick Ratio (X) | 0.49 | 0.60 | 0.72 | 0.62 | 0.45 |
| Interest Coverage Ratio (X) | 0.71 | 2.37 | 3.76 | 6.23 | 1.02 |
| Interest Coverage Ratio (Post Tax) (X) | -0.50 | 0.53 | 2.00 | 5.04 | -0.09 |
| Enterprise Value (Cr.) | 30.27 | 32.82 | 19.95 | 24.68 | 15.65 |
| EV / Net Operating Revenue (X) | 0.86 | 0.85 | 0.69 | 0.78 | 0.80 |
| EV / EBITDA (X) | 46.65 | 15.06 | 5.95 | 4.02 | 13.54 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| Price / BV (X) | -12.21 | -77.01 | 114.51 | -22.26 | -1.53 |
| Price / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| EarningsYield | -0.05 | -0.01 | 0.06 | 0.22 | -0.17 |
After reviewing the key financial ratios for Chennai Meenakshi Multispeciality Hospital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from 0.97 (Mar 24) to -0.28, marking a decrease of 1.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.62. It has decreased from 51.15 (Mar 24) to 46.62, marking a decrease of 4.53.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 2. It has decreased from 2.92 (Mar 24) to 0.86, marking a decrease of 2.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.37 (Mar 24) to -0.68, marking a decrease of 2.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.91. This value is below the healthy minimum of 0. It has decreased from 0.13 (Mar 24) to -1.91, marking a decrease of 2.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 2. It has decreased from -0.57 (Mar 24) to -1.84, marking a decrease of 1.27.
- For PBDIT Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 10. It has decreased from 5.70 (Mar 24) to 1.86, marking a decrease of 3.84.
- For PBIT Margin (%), as of Mar 25, the value is -1.47. This value is below the healthy minimum of 10. It has decreased from 2.67 (Mar 24) to -1.47, marking a decrease of 4.14.
- For PBT Margin (%), as of Mar 25, the value is -4.10. This value is below the healthy minimum of 10. It has decreased from 0.27 (Mar 24) to -4.10, marking a decrease of 4.37.
- For Net Profit Margin (%), as of Mar 25, the value is -3.94. This value is below the healthy minimum of 5. It has decreased from -1.11 (Mar 24) to -3.94, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.00. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to -5.00, marking a decrease of 13.42.
- For Return On Assets (%), as of Mar 25, the value is -6.10. This value is below the healthy minimum of 5. It has decreased from -1.87 (Mar 24) to -6.10, marking a decrease of 4.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -5.63. This value is below the healthy minimum of 0.2. It has increased from -33.52 (Mar 24) to -5.63, marking an increase of 27.89.
- For Total Debt / Equity (X), as of Mar 25, the value is -5.63. This value is within the healthy range. It has increased from -34.86 (Mar 24) to -5.63, marking an increase of 29.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has decreased from 1.69 (Mar 24) to 1.54, marking a decrease of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1.5. It has decreased from 0.64 (Mar 24) to 0.53, marking a decrease of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.49, marking a decrease of 0.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 3. It has decreased from 2.37 (Mar 24) to 0.71, marking a decrease of 1.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 3. It has decreased from 0.53 (Mar 24) to -0.50, marking a decrease of 1.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 30.27. It has decreased from 32.82 (Mar 24) to 30.27, marking a decrease of 2.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.85 (Mar 24) to 0.86, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 46.65. This value exceeds the healthy maximum of 15. It has increased from 15.06 (Mar 24) to 46.65, marking an increase of 31.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For Price / BV (X), as of Mar 25, the value is -12.21. This value is below the healthy minimum of 1. It has increased from -77.01 (Mar 24) to -12.21, marking an increase of 64.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.05, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chennai Meenakshi Multispeciality Hospital Ltd:
- Net Profit Margin: -3.94%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.49
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 71.93)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -5.63
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.94%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | New No.70, Old No.149, Luz Church Road, Chennai (Madras) Tamil Nadu 600004 | cmmhospitals@gmail.com http://www.cmmh.in |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. R Gomathi | Managing Director |
| Mrs. Jayanthi Radhakrishnan | Non Executive Director |
| Mr. K Meyyanathan | Independent Director |
| Mr. N Rajkumar | Independent Director |
FAQ
What is the intrinsic value of Chennai Meenakshi Multispeciality Hospital Ltd?
Chennai Meenakshi Multispeciality Hospital Ltd's intrinsic value (as of 29 October 2025) is 4.65 which is 91.23% lower the current market price of 53.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 39.6 Cr. market cap, FY2025-2026 high/low of 59.9/28.3, reserves of ₹-9.36 Cr, and liabilities of 22.50 Cr.
What is the Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd?
The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd is 39.6 Cr..
What is the current Stock Price of Chennai Meenakshi Multispeciality Hospital Ltd as on 29 October 2025?
The current stock price of Chennai Meenakshi Multispeciality Hospital Ltd as on 29 October 2025 is 53.0.
What is the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks is 59.9/28.3.
What is the Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd?
The Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd is .
What is the Book Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Book Value of Chennai Meenakshi Multispeciality Hospital Ltd is 2.53.
What is the Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd?
The Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd is 0.00 %.
What is the ROCE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROCE of Chennai Meenakshi Multispeciality Hospital Ltd is 5.14 %.
What is the ROE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROE of Chennai Meenakshi Multispeciality Hospital Ltd is %.
What is the Face Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Face Value of Chennai Meenakshi Multispeciality Hospital Ltd is 10.0.